Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0236 EUR | -16.90% | -21.33% | +55.26% |
11/06 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
27/05 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |